Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57K Sell
428
-13
-3% -$1.47K ﹤0.01% 653
2026
Q1
$49.1K Buy
441
+13
+3% +$1.54K ﹤0.01% 625
2025
Q4
$57.7K Hold
428
﹤0.01% 635
2025
Q3
$36.3K Buy
+428
New +$26.2K ﹤0.01% 687

Other funds holding ABVX

First Horizon Corporation's ABVX Position: Q2 2026 in Review

First Horizon Corporation reduced its Abivax (ABVX) stake by 2.9% in Q2 2026, selling an estimated $1.47K and leaving 428 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

First Horizon Corporation first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $57.7K in Q4 2025. 67 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • First Horizon Corporation held 428 shares of Abivax worth $57K as of Q2 2026.
  • First Horizon Corporation sold 13 Abivax shares in Q2 2026, an estimated $1.47K.
  • Abivax made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #653 holding.
  • First Horizon Corporation first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Abivax position peaked at $57.7K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.